Global Latent TB Infection Testing Market Growth (Status and Outlook) 2021-2026

Publisher Name :
Date: 13-Oct-2021
No. of pages: 104

According to this latest study, the 2021 growth of Latent TB Infection Testing will have significant change from previous year. By the most conservative estimates of global Latent TB Infection Testing market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Latent TB Infection Testing market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Latent TB Infection Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

- Mantoux Test / Tuberculin Skin Test (TST)

- Interferon-Gamma Release Assay (IGRA)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

- Hospitals

- Public and Student Health

- Physician Offices and Clinics

- Others (Military, Correctional Facilities, Chronic Care Homes, and Others)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)

- Pharmstandard (Generium Pharmaceutical)

- Sanofi S.A./Sanofi Pasteur Ltd.

- Statens Serum Institut (SSI)

- Autoimmun Diagnostika (AID) GmbH

- Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

- Haikou VTI Biological Institute (Vaccine Technologies, Inc.)

- Immunoshop India Pvt. Ltd.

- Qiagen N.V.

- Quest Diagnostics, Inc. (Oxford Immunotec Global plc)

- SD Biosensor, Inc.

Global Latent TB Infection Testing Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Latent TB Infection Testing Market Size 2016-2026
2.1.2 Latent TB Infection Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Latent TB Infection Testing Segment by Type
2.2.1 Mantoux Test / Tuberculin Skin Test (TST)
2.2.2 Mantoux Test / Tuberculin Skin Test (TST)
2.3 Latent TB Infection Testing Market Size by Type
2.3.1 Global Latent TB Infection Testing Market Size CAGR by Type
2.3.2 Global Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
2.4 Latent TB Infection Testing Segment by Application
2.4.1 Hospitals
2.4.2 Public and Student Health
2.4.3 Physician Offices and Clinics
2.4.4 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
2.5 Latent TB Infection Testing Market Size by Application
2.5.1 Global Latent TB Infection Testing Market Size CAGR by Application
2.5.2 Global Latent TB Infection Testing Market Size Market Share by Application (2016-2021)

3 Latent TB Infection Testing Market Size by Players
3.1 Latent TB Infection Testing Market Size Market Share by Players
3.1.1 Global Latent TB Infection Testing Revenue by Players (2019-2021E)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Latent TB Infection Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Latent TB Infection Testing by Regions
4.1 Latent TB Infection Testing Market Size by Regions (2016-2021)
4.2 Americas Latent TB Infection Testing Market Size Growth (2016-2021)
4.3 APAC Latent TB Infection Testing Market Size Growth (2016-2021)
4.4 Europe Latent TB Infection Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Latent TB Infection Testing Market Size Growth (2016-2021)

5 Americas
5.1 Americas Latent TB Infection Testing Market Size by Country (2016-2021)
5.2 Americas Latent TB Infection Testing Market Size by Type (2016-2021)
5.3 Americas Latent TB Infection Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Latent TB Infection Testing Market Size by Region (2016-2021)
6.2 APAC Latent TB Infection Testing Market Size by Type (2016-2021)
6.3 APAC Latent TB Infection Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Latent TB Infection Testing by Country (2016-2021)
7.2 Europe Latent TB Infection Testing Market Size by Type (2016-2021)
7.3 Europe Latent TB Infection Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Latent TB Infection Testing by Region (2016-2021)
8.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Latent TB Infection Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Latent TB Infection Testing Market Forecast
10.1 Global Latent TB Infection Testing Forecast by Regions (2021-2026)
10.1.1 Global Latent TB Infection Testing Forecast by Regions (2021-2026)
10.1.2 Americas Latent TB Infection Testing Forecast
10.1.3 APAC Latent TB Infection Testing Forecast
10.1.4 Europe Latent TB Infection Testing Forecast
10.1.5 Middle East & Africa Latent TB Infection Testing Forecast
10.2 Americas Latent TB Infection Testing Forecast by Countries (2021-2026)
10.2.1 United States Latent TB Infection Testing Market Forecast
10.2.2 Canada Latent TB Infection Testing Market Forecast
10.2.3 Mexico Latent TB Infection Testing Market Forecast
10.2.4 Brazil Latent TB Infection Testing Market Forecast
10.3 APAC Latent TB Infection Testing Forecast by Region (2021-2026)
10.3.1 China Latent TB Infection Testing Market Forecast
10.3.2 Japan Latent TB Infection Testing Market Forecast
10.3.3 Korea Latent TB Infection Testing Market Forecast
10.3.4 Southeast Asia Latent TB Infection Testing Market Forecast
10.3.5 India Latent TB Infection Testing Market Forecast
10.3.6 Australia Latent TB Infection Testing Market Forecast
10.4 Europe Latent TB Infection Testing Forecast by Country (2021-2026)
10.4.1 Germany Latent TB Infection Testing Market Forecast
10.4.2 France Latent TB Infection Testing Market Forecast
10.4.3 UK Latent TB Infection Testing Market Forecast
10.4.4 Italy Latent TB Infection Testing Market Forecast
10.4.5 Russia Latent TB Infection Testing Market Forecast
10.5 Middle East & Africa Latent TB Infection Testing Forecast by Region (2021-2026)
10.5.1 Egypt Latent TB Infection Testing Market Forecast
10.5.2 South Africa Latent TB Infection Testing Market Forecast
10.5.3 Israel Latent TB Infection Testing Market Forecast
10.5.4 Turkey Latent TB Infection Testing Market Forecast
10.5.5 GCC Countries Latent TB Infection Testing Market Forecast
10.6 Global Latent TB Infection Testing Forecast by Type (2021-2026)
10.7 Global Latent TB Infection Testing Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Information
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business Overview
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Information
11.2.2 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Pharmstandard (Generium Pharmaceutical) Main Business Overview
11.2.5 Pharmstandard (Generium Pharmaceutical) Latest Developments
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Information
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Main Business Overview
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Information
11.4.2 Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Statens Serum Institut (SSI) Main Business Overview
11.4.5 Statens Serum Institut (SSI) Latest Developments
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Information
11.5.2 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Autoimmun Diagnostika (AID) GmbH Main Business Overview
11.5.5 Autoimmun Diagnostika (AID) GmbH Latest Developments
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Information
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business Overview
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Information
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business Overview
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Information
11.8.2 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Immunoshop India Pvt. Ltd. Main Business Overview
11.8.5 Immunoshop India Pvt. Ltd. Latest Developments
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Information
11.9.2 Qiagen N.V. Latent TB Infection Testing Product Offered
11.9.3 Qiagen N.V. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Qiagen N.V. Main Business Overview
11.9.5 Qiagen N.V. Latest Developments
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Information
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business Overview
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
11. SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Information
11.11.2 SD Biosensor, Inc. Latent TB Infection Testing Product Offered
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 SD Biosensor, Inc. Main Business Overview
11.11.5 SD Biosensor, Inc. Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Latent TB Infection Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Major Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Latent TB Infection Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Latent TB Infection Testing Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
Table 7. Latent TB Infection Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Latent TB Infection Testing Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Latent TB Infection Testing Market Size Market Share by Application (2016-2021)
Table 10. Global Latent TB Infection Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Latent TB Infection Testing Revenue Market Share by Players (2019-2021E)
Table 12. Latent TB Infection Testing Key Players Head office and Products Offered
Table 13. Latent TB Infection Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Latent TB Infection Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Latent TB Infection Testing Market Size Market Share by Regions 2016-2021
Table 18. Americas Latent TB Infection Testing Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Latent TB Infection Testing Market Size Market Share by Country (2016-2021)
Table 20. Americas Latent TB Infection Testing Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
Table 22. Americas Latent TB Infection Testing Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Latent TB Infection Testing Market Size Market Share by Application (2016-2021)
Table 24. APAC Latent TB Infection Testing Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Latent TB Infection Testing Market Size Market Share by Region (2016-2021)
Table 26. APAC Latent TB Infection Testing Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
Table 28. APAC Latent TB Infection Testing Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Latent TB Infection Testing Market Size Market Share by Application (2016-2021)
Table 30. Europe Latent TB Infection Testing Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Latent TB Infection Testing Market Size Market Share by Country (2016-2021)
Table 32. Europe Latent TB Infection Testing Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
Table 34. Europe Latent TB Infection Testing Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Latent TB Infection Testing Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Latent TB Infection Testing Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Latent TB Infection Testing Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Latent TB Infection Testing Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Latent TB Infection Testing
Table 43. Key Application and Potential Industries of Latent TB Infection Testing
Table 44. Key Challenges of Latent TB Infection Testing
Table 45. Key Trends of Latent TB Infection Testing
Table 46. Global Latent TB Infection Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Latent TB Infection Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Latent TB Infection Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Latent TB Infection Testing Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Latent TB Infection Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Latent TB Infection Testing Market Size Market Share Forecast by Application (2021-2026)
Table 52. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 53. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
Table 54. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business
Table 56. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
Table 57. Pharmstandard (Generium Pharmaceutical) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 58. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
Table 59. Pharmstandard (Generium Pharmaceutical) Main Business
Table 60. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Pharmstandard (Generium Pharmaceutical) Latest Developments
Table 62. Sanofi S.A./Sanofi Pasteur Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 63. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
Table 64. Sanofi S.A./Sanofi Pasteur Ltd. Main Business
Table 65. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
Table 67. Statens Serum Institut (SSI) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 68. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
Table 69. Statens Serum Institut (SSI) Main Business
Table 70. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Statens Serum Institut (SSI) Latest Developments
Table 72. Autoimmun Diagnostika (AID) GmbH Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 73. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
Table 74. Autoimmun Diagnostika (AID) GmbH Main Business
Table 75. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Autoimmun Diagnostika (AID) GmbH Latest Developments
Table 77. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 78. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
Table 79. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business
Table 80. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
Table 82. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 83. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
Table 84. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business
Table 85. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
Table 87. Immunoshop India Pvt. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 88. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
Table 89. Immunoshop India Pvt. Ltd. Main Business
Table 90. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Immunoshop India Pvt. Ltd. Latest Developments
Table 92. Qiagen N.V. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 93. Qiagen N.V. Latent TB Infection Testing Product Offered
Table 94. Qiagen N.V. Main Business
Table 95. Qiagen N.V. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Qiagen N.V. Latest Developments
Table 97. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 98. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
Table 99. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business
Table 100. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
Table 102. SD Biosensor, Inc. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 103. SD Biosensor, Inc. Latent TB Infection Testing Product Offered
Table 104. SD Biosensor, Inc. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. SD Biosensor, Inc. Main Business
Table 106. SD Biosensor, Inc. Latest Developments
List of Figures
Figure 1. Latent TB Infection Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent TB Infection Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Latent TB Infection Testing Market Size Market Share by Type in 2020
Figure 7. Latent TB Infection Testing in Hospitals
Figure 8. Global Latent TB Infection Testing Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Latent TB Infection Testing in Public and Student Health
Figure 10. Global Latent TB Infection Testing Market: Public and Student Health (2016-2021) & ($ Millions)
Figure 11. Latent TB Infection Testing in Physician Offices and Clinics
Figure 12. Global Latent TB Infection Testing Market: Physician Offices and Clinics (2016-2021) & ($ Millions)
Figure 13. Latent TB Infection Testing in Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
Figure 14. Global Latent TB Infection Testing Market: Others (Military, Correctional Facilities, Chronic Care Homes, and Others) (2016-2021) & ($ Millions)
Figure 15. Global Latent TB Infection Testing Market Size Market Share by Application in 2020
Figure 16. Global Latent TB Infection Testing Revenue Market Share by Player in 2020
Figure 17. Global Latent TB Infection Testing Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Latent TB Infection Testing Market Size 2016-2021 ($ Millions)
Figure 19. APAC Latent TB Infection Testing Market Size 2016-2021 ($ Millions)
Figure 20. Europe Latent TB Infection Testing Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Latent TB Infection Testing Market Size 2016-2021 ($ Millions)
Figure 22. Americas Latent TB Infection Testing Market Size Market Share by Country in 2020
Figure 23. Americas Latent TB Infection Testing Market Size Market Share by Type in 2020
Figure 24. Americas Latent TB Infection Testing Market Size Market Share by Application in 2020
Figure 25. United States Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Latent TB Infection Testing Market Size Market Share by Regions in 2020
Figure 29. APAC Latent TB Infection Testing Market Size Market Share by Type in 2020
Figure 30. APAC Latent TB Infection Testing Market Size Market Share by Application in 2020
Figure 31. China Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Latent TB Infection Testing Market Size Market Share by Country in 2020
Figure 38. Europe Latent TB Infection Testing Market Size Market Share by Type in 2020
Figure 39. Europe Latent TB Infection Testing Market Size Market Share by Application in 2020
Figure 40. Germany Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application in 2020
Figure 48. Egypt Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Latent TB Infection Testing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 54. APAC Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 55. Europe Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 57. United States Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 58. Canada Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 61. China Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 62. Japan Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 63. Korea Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 65. India Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 66. Australia Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 67. Germany Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 68. France Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 69. UK Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 70. Italy Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 71. Russia Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 72. Spain Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 75. Israel Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Latent TB Infection Testing Market Size 2021-2026 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs